Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-κB/NLRP3 pathways in inflammatory endothelial cells
Abstract Atherosclerosis, a chronic inflammatory disease characterized by arterial plaque formation, is one of the most prominent causes of cardiovascular diseases. However, the current treatments often do not adequately compromise the chronic inflammation-mediated plaque accumulation and the diseas...
Main Authors: | Juan Tang, Tao Li, Xiaojing Xiong, Qiaoyun Yang, Zedazhong Su, Minming Zheng, Qingwei Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-023-02228-z |
Similar Items
-
Anti-malarial artesunate ameliorates atherosclerosis by modulating arterial inflammatory responses via inhibiting the NF-κB–NLRP3 inflammasome pathway
by: Yanyan Cen, et al.
Published: (2023-02-01) -
Colchicine prevents oxidative stress-induced endothelial cell senescence via blocking NF-κB and MAPKs: implications in vascular diseases
by: Huakang Zhou, et al.
Published: (2023-11-01) -
The Role of Colchicine in Atherosclerosis: From Bench to Bedside
by: Leticia González, et al.
Published: (2022-07-01) -
NF-κB and its crosstalk with endoplasmic reticulum stress in atherosclerosis
by: Wenjing Li, et al.
Published: (2022-09-01) -
Acacetin inhibits inflammation by blocking MAPK/NF-κB pathways and NLRP3 inflammasome activation
by: Juan Bu, et al.
Published: (2024-02-01)